Here's the live share price of Laurus Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Laurus Labs has gained 23.47% CAGR. Over the past year, the corresponding return has been 79.08%.
Laurus Labs’s current P/E of 80.19x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Laurus Labs | -0.22 | 0.98 | 10.07 | 53.14 | 79.08 | 37.85 | 23.47 |
| Sun Pharmaceutical Industries | -3.37 | -0.78 | 5.89 | 5.97 | -3.02 | 20.90 | 24.86 |
| Divi's Laboratories | -0.68 | -1.34 | 4.69 | -2.29 | 9.24 | 24.04 | 10.77 |
| Torrent Pharmaceuticals | -0.94 | -0.73 | 5.57 | 16.70 | 11.39 | 33.11 | 22.12 |
| Cipla | -0.96 | -1.13 | -5.12 | -0.05 | 1.73 | 10.95 | 13.53 |
| Dr. Reddy's Laboratories | 0.52 | 2.90 | -3.24 | -2.53 | 0.36 | 13.31 | 4.11 |
| Lupin | 1.86 | 3.51 | 3.57 | 8.46 | 0.97 | 42.74 | 16.86 |
| Zydus Lifesciences | -1.35 | -1.97 | -13.16 | -4.99 | -7.06 | 30.52 | 13.82 |
| Mankind Pharma | -1.46 | -4.00 | -19.07 | -9.31 | -23.90 | 14.45 | 8.44 |
| Aurobindo Pharma | 3.28 | -2.30 | 7.31 | 9.39 | -2.95 | 40.38 | 6.45 |
| Alkem Laboratories | -2.10 | -3.58 | 0.51 | 14.62 | 0.39 | 22.43 | 13.24 |
| Abbott India | -1.27 | -6.14 | -9.87 | -11.54 | -0.94 | 10.11 | 11.52 |
| Glenmark Pharmaceuticals | -0.05 | 6.17 | -7.33 | 17.78 | 28.29 | 67.47 | 30.53 |
| Biocon | 2.56 | -7.19 | 6.23 | 14.37 | 12.46 | 14.16 | -3.66 |
| GlaxoSmithKline Pharmaceuticals | -3.21 | 2.09 | -7.63 | -22.68 | 8.77 | 24.02 | 9.53 |
| Anthem Biosciences | -1.47 | 2.40 | -21.05 | -7.58 | -7.58 | -2.59 | -1.56 |
| Ipca Laboratories | -3.52 | -0.35 | 6.01 | 4.11 | -6.44 | 18.41 | 4.91 |
| Ajanta Pharma | -1.71 | 5.89 | 2.29 | 0.97 | -9.93 | 30.31 | 18.84 |
| J B Chemicals & Pharmaceuticals | -1.37 | -0.53 | 5.82 | 4.08 | -3.60 | 20.22 | 27.44 |
| Gland Pharma | -1.70 | -7.01 | -17.51 | -4.00 | -5.66 | -0.25 | -5.65 |
Over the last one year, Laurus Labs has gained 79.08% compared to peers like Sun Pharmaceutical Industries (-3.02%), Divi's Laboratories (9.24%), Torrent Pharmaceuticals (11.39%). From a 5 year perspective, Laurus Labs has outperformed peers relative to Sun Pharmaceutical Industries (24.86%) and Divi's Laboratories (10.77%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,015.39 | 1,008.63 |
| 10 | 1,015.75 | 1,010.5 |
| 20 | 1,006.32 | 1,004.69 |
| 50 | 962.58 | 970.77 |
| 100 | 916.83 | 911.71 |
| 200 | 778.18 | 813.94 |
In the latest quarter, Laurus Labs saw a drop in promoter holding to 27.59%, while DII stake decreased to 11.72%, FII holding rose to 26.17%, and public shareholding moved up to 34.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 66,71,181 | 1.58 | 688.03 | |
| 50,23,466 | 1.9 | 518.1 | |
| 38,00,000 | 1.06 | 391.91 | |
| 28,22,588 | 1.58 | 291.11 | |
| 21,17,487 | 0.82 | 218.39 | |
| 19,14,476 | 6.21 | 197.45 | |
| 14,00,000 | 3.5 | 144.39 | |
| 11,00,000 | 1.85 | 113.45 | |
| 9,64,750 | 0.49 | 99.5 | |
| 8,91,870 | 2.12 | 91.98 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Dec 12, 2025, 8:59 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Dec 02, 2025, 8:15 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Nov 19, 2025, 5:40 AM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 12, 2025, 5:27 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 28, 2025, 10:03 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 5216.98 Cr. and Equity Capital is Rs. 107.85 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Laurus Labs is ₹1,015.90 as on Dec 18, 2025.
The Laurus Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Laurus Labs is ₹54,844.03 Cr as on Dec 18, 2025.
Today’s highest and lowest price of Laurus Labs are ₹1,019.50 and ₹998.15.
The 52-week high/low is the highest and lowest price at which Laurus Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Laurus Labs is ₹1,040.00 and 52-week low of Laurus Labs is ₹504.30 as on Dec 18, 2025.
The Laurus Labs has shown returns of 0.66% over the past day, 0.98% for the past month, 10.07% over 3 months, 79.08% over 1 year, 37.85% across 3 years, and 23.47% over 5 years.
P/E ratio of and PB ratio of Laurus Labs are 80.19 and 12.26 on Dec 18, 2025. While the company gives a dividend yield of 0.12 per annum.